Big Pharma and WHO collude to create permanent market for EXPERIMENTAL injections

08/13/2024 / By Ava Grace

The globalist World Health Organization (WHO) and Big Pharma have colluded to create a permanent market for “vaccines” and other experimental treatments, ensuring the uninterrupted flow of revenue.

Max Jones of Unlimited Hangout first disclosed the development in an investigative report. According to him, Big Pharma and its key investors are now pivoting toward “the full takeover of the public sector, specifically the WHO, and the regulatory system that now holds the entire market hostage. Jones added that the pivot seeks to address the so-called “patent cliff” – the loss of revenue that followed the expiry of patents for certain drugs, which manufacturers of generic medicines quickly capitalized on.

A February 2023 report by Biopharma Dive expounded on the patent cliff, noting that “blockbuster medicines that had fueled years of growth were losing patent protection.” This exposed pharmaceutical giants to generic competitors.

Jones said that to ensure continued profits, Big Pharma firms deployed a “mergers and acquisitions” strategy for years, buying up smaller drug companies to add to their product portfolios. Because of this, the industry is now dominated by a handful of companies, conventional chemical drugs exist for most health issues, and the regulatory process for new ones has become onerous.

But now, pharmaceutical giants are facing an even larger patent cliff in the form of biological products manufactured from living cells. These products could lose market exclusivity, with more than $200 billion in annual revenue on the line through 2030.

Given this, Big Pharma has now sought to acquire biotechnology and biologic companies whose products are “more complex, unpredictable and difficult and expensive to make” than chemical-based medicine. According to the Defender, biologics offer an appealing solution to the patent cliff problem as they can’t be easily replicated like generic versions of conventional drugs.

Max Jones: WHO is an arm of Big Pharma

But Jones pointed out in his investigative report that the serious safety issues associated with the Wuhan coronavirus (COVID-19) vaccine make it difficult for drug firms to find commercial success in a conventional regulatory environment. (Related: Korean scientists claim Pfizer, Moderna mRNA vaccine vials contain self-assembling nanoparticles that can form into clots.)

He added that luck was on Big Pharma’s side as the WHO and its private backers, “are pursuing an unprecedented legal process that would cement loopholes that could solve these significant market challenges of at least some biotechnologies.” Such loopholes, according to Jones, contributed to the “market success” of the mRNA COVID-19 vaccines by Pfizer and Moderna.

Jones also noted how “fast-tracked, deregulated development and mandated consumption of the experimental drugs” enabled the distribution of the COVID-19 injections to approximately 70 percent of people around the world. This could happen again, as he mentioned the Biomedical Advanced Research and Development Authority – an agency under the U.S. Department of Health and Human Services – giving Moderna $176 million to develop an mRNA bird flu vaccine.

According to his report, the process of rapidly developed and mandated experimental drugs was first adopted by the U.S. military for bioweapons threats. This time, the global health body – via its revisions to the International Health Regulations (IHR) and its continued attempt to push the so-called pandemic treaty – seeks to internationally legitimize this process.

During the last meeting of the World Health Assembly in June, the IHR amendments were watered down and the pandemic treaty was partially thwarted. But the WHO and its backers are still hoping to advance these next year.

“At the forefront of this push are WHO’s public-private-partners/private stakeholders, who directly shape and benefit from this policy,” Jones wrote. “Their influence has, in effect, turned the WHO into an arm of Big Pharma , one so powerful that it already demonstrated its ability to morph the entire international regulatory process for the benefit of the pharmaceutical industry during the COVID-19 pandemic.”

Watch this clip from Zeee Media about the WHO seemingly resuming its negotiations for the so-called pandemic treaty.

This video is from the Tanjerea channel on Brighteon.com.